When to monitor CD4 cell count and HIV RNA to reduce mortality and aids-defining illness in virologically suppressed hiv-positive persons on antiretroviral therapy in high-income countries: A prospective observational study

  1. Caniglia, E.C.
  2. Sabin, C.
  3. Robins, J.M.
  4. Logan, R.
  5. Cain, L.E.
  6. Abgrall, S.
  7. Mugavero, M.J.
  8. Hernandez-DIaz, S.
  9. Meyer, L.
  10. Seng, R.
  11. Drozd, D.R.
  12. Seage, G.R.
  13. Bonnet, F.
  14. Dabis, F.
  15. Moore, R.R.
  16. Reiss, P.
  17. Van Sighem, A.
  18. Mathews, W.C.
  19. Del Amo, J.
  20. Moreno, S.
  21. Deeks, S.G.
  22. Muga, R.
  23. Boswell, S.L.
  24. Ferrer, E.
  25. Eron, J.J.
  26. Napravnik, S.
  27. Jose, S.
  28. Phillips, A.
  29. Olson, A.
  30. Justice, A.C.
  31. Tate, J.P.
  32. Bucher, H.C.
  33. Egger, M.
  34. Touloumi, G.
  35. Sterne, J.A.
  36. Costagliola, D.
  37. Saag, M.
  38. Hernán, M.A.
  39. Erakutsi egile guztiak +
Aldizkaria:
Journal of Acquired Immune Deficiency Syndromes

ISSN: 1077-9450 1525-4135

Argitalpen urtea: 2016

Alea: 72

Zenbakia: 2

Orrialdeak: 214-221

Mota: Artikulua

DOI: 10.1097/QAI.0000000000000956 GOOGLE SCHOLAR